Maven Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-702
Closed -$617K 987
2023
Q4
$617K Buy
702
+411
+141% +$338K 0.07% 603
2023
Q3
$239K Buy
+291
New +$229K 0.03% 1003
2023
Q2
Hold
0
1183
2023
Q1
Hold
0
1232
2022
Q4
Hold
0
1146
2022
Q3
Sell
-1,238
Closed -$779K 1271
2022
Q2
$732K Buy
1,238
+812
+191% +$528K 0.13% 460
2022
Q1
$298K Buy
426
+26
+7% +$16.4K 0.06% 706
2021
Q4
$253K Buy
+400
New +$246K 0.03% 733
2021
Q3
Hold
0
1362
2021
Q2
Sell
-520
Closed -$263K 1407
2021
Q1
$246K Sell
520
-1,078
-67% -$525K 0.02% 871
2020
Q4
$772K Buy
1,598
+616
+63% +$333K 0.08% 284
2020
Q3
$557K Buy
982
+610
+164% +$370K 0.08% 359
2020
Q2
$232K Buy
+372
New +$211K 0.06% 475

Other funds holding REGN